ZA839023B - Spiro-3-hetero-azolones for treatment of diabetic complications - Google Patents
Spiro-3-hetero-azolones for treatment of diabetic complicationsInfo
- Publication number
- ZA839023B ZA839023B ZA839023A ZA839023A ZA839023B ZA 839023 B ZA839023 B ZA 839023B ZA 839023 A ZA839023 A ZA 839023A ZA 839023 A ZA839023 A ZA 839023A ZA 839023 B ZA839023 B ZA 839023B
- Authority
- ZA
- South Africa
- Prior art keywords
- azolones
- spiro
- hetero
- treatment
- diabetic complications
- Prior art date
Links
- 208000002249 Diabetes Complications Diseases 0.000 title 1
- 206010012655 Diabetic complications Diseases 0.000 title 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44733782A | 1982-12-06 | 1982-12-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA839023B true ZA839023B (en) | 1985-07-31 |
Family
ID=23775964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA839023A ZA839023B (en) | 1982-12-06 | 1983-12-05 | Spiro-3-hetero-azolones for treatment of diabetic complications |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS59116274A (enrdf_load_stackoverflow) |
| CS (1) | CS244683B2 (enrdf_load_stackoverflow) |
| DD (1) | DD234265A5 (enrdf_load_stackoverflow) |
| HU (1) | HU193191B (enrdf_load_stackoverflow) |
| IN (1) | IN160449B (enrdf_load_stackoverflow) |
| SU (1) | SU1380610A3 (enrdf_load_stackoverflow) |
| ZA (1) | ZA839023B (enrdf_load_stackoverflow) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4575507A (en) * | 1985-05-29 | 1986-03-11 | Pfizer Inc. | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
| GB2355264A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
| PL2444085T3 (pl) * | 2005-05-13 | 2015-07-31 | Univ California | Związki diarylohydantoinowe jako antagoniści receptora androgenów do leczenia raka |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
| US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
-
1983
- 1983-12-05 HU HU416183A patent/HU193191B/hu not_active IP Right Cessation
- 1983-12-05 SU SU833674609A patent/SU1380610A3/ru active
- 1983-12-05 ZA ZA839023A patent/ZA839023B/xx unknown
- 1983-12-06 DD DD27521983A patent/DD234265A5/de not_active IP Right Cessation
- 1983-12-06 JP JP23048683A patent/JPS59116274A/ja active Granted
- 1983-12-06 CS CS839130A patent/CS244683B2/cs unknown
- 1983-12-14 IN IN838/DEL/83A patent/IN160449B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS244683B2 (en) | 1986-08-14 |
| HU193191B (en) | 1987-08-28 |
| JPH0251548B2 (enrdf_load_stackoverflow) | 1990-11-07 |
| CS913083A2 (en) | 1985-09-17 |
| SU1380610A3 (ru) | 1988-03-07 |
| IN160449B (enrdf_load_stackoverflow) | 1987-07-11 |
| DD234265A5 (de) | 1986-03-26 |
| JPS59116274A (ja) | 1984-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3377263D1 (en) | Skin treatment composition | |
| GB8322218D0 (en) | Treatment of cancers | |
| PH19559A (en) | Celiprolol for the treatment of galucoma | |
| GB8319365D0 (en) | Treatment of metals | |
| GB2141929B (en) | Treatment of footrot | |
| GB8321131D0 (en) | Treatment of meat | |
| DE3379043D1 (en) | Spiro-3-hetero-azolones for treatment of diabetic complications | |
| PH17865A (en) | Method of treatment | |
| DE3174448D1 (en) | Combinations for the treatment of wounds | |
| GB8318991D0 (en) | Agent for treatment of wounds | |
| ZA839023B (en) | Spiro-3-hetero-azolones for treatment of diabetic complications | |
| DE3561198D1 (en) | Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications | |
| DE3272384D1 (en) | Medicinal composition for the treatment of certain neuroviroses | |
| GB2125319B (en) | Surface treatment of footwear | |
| JPS5781804A (en) | Improvement of treatment of substance | |
| DE3371869D1 (en) | Apparatus for blood treatment | |
| ZA83662B (en) | Skin treatment composition | |
| JPS56893A (en) | Treatment of moxious matter compound | |
| AU559170B2 (en) | Cloxacillin treatment | |
| EG16732A (en) | Spiro 3-hetero azolones for treatment of diabetic compications | |
| PH17726A (en) | Treatment for diabetic complications | |
| ZA829106B (en) | Treatment for diabetic complications | |
| GB2122225B (en) | After treatment of dyeings afterchroming | |
| BG35205A1 (en) | Means for treatment of seborean dermathite | |
| DE3369271D1 (en) | Treatment of timber |